What are the recommended clinical assessment and screening tests during pregnancy?

Gyselaers W, Jonckheer P, Ahmadzai N, T. Ansari M, Carville S, Dworzynski K, Gaudet L, Glen J, Jones K, Miller P, Tetzlaff J M, Alexander S, Allegaert K, Beeckman K, Ceysens G, Christiane Y, De Ronne N, de Thysebaert B, Dekker N, Denys A, Eeckeleers P, Hernandez A, Mathieu E, Seuntjens L, Verleye L, Stordeur S
Record ID 32015000831
Authors' objectives: The aim of this project is to update the KCE 2004 guideline for antenatal care in low-risk women with a particular attention to emerging clinical questions. It was decided to focus on low-risk pregnant women, i.e. women who do not have identified risk factors, known pre-existing conditions or complications requiring additional tests or adapted management. The main scope of this guideline was also delineated and focuses on the monitoring and the follow-up of pregnant women including: - Schedule of antenatal visits - Clinical examination - Technical examination - Haematologial assessment - Screening tests for infections - Screening for maternal clinical problems - Screening for specific pregnancy related risks
Project Status: Completed
Year Published: 2015
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Belgium
MeSH Terms
  • Mass Screening
  • Predictive Value of Tests
  • Sensitivity and Specificity
  • Genetic Testing
  • Pregnancy
  • Pregnancy Complications
  • Pregnancy Tests
Organisation Name: Belgian Health Care Knowledge Centre
Contact Address: Administrative Centre Botanique, Doorbuilding (10th floor), Boulevard du Jardin Botanique 55, B-1000 Brussels, Belgium tel: +32 2 287 33 88 fax: +32 2 287 33 85
Contact Name: info@kce.fgov.be
Contact Email: info@kce.fgov.be
Copyright: Belgian Health Care Knowledge Centre (KCE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.